Brief: Sienna Biopharmaceuticals Qtrly Loss Per Share $0.56
15/03/2018 13:14
March 15 (Reuters) - Sienna Biopharmaceuticals Inc SNNA.O :
* SIENNA BIOPHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL
YEAR
2017 FINANCIAL RESULTS
* SIENNA BIOPHARMACEUTICALS INC - CASH AND CASH EQUIVALENTS
AS OF
DEC 31, 2017 TOTALED APPROXIMATELY $74.5 MILLION
* SIENNA BIOPHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.56
Source text for Eikon: ID:nGNX8lnwhW
Further company coverage: SNNA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sienna Biopharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Adobe, Oracle, Snap, Phreesia, Sarepta, Aquestive Therapeutics, Patterson-UTI
U.S. STOCKS ON THE MOVE-Lululemon, GE, Starbucks, Delta Air Lines, Lumber Liquidators, Lovesac
Sienna Biopharma: Falls on Nasdaq delisting plans
Brief: Sienna Biopharma Says Bankruptcy Court Approved Sale Of Assets Related To SNA-001 For $1.7 Mln In Cash
Brief: Sienna Biopharmaceuticals Announces Court Approval Of Chapter 11 Bidding Procedures